1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Neuroleptic Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Neuroleptic by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Neuroleptic by Country/Region, 2017, 2022 & 2028 2.2 Neuroleptic Segment by Type 2.2.1 Droperidol 2.2.2 Midazolam 2.3 Neuroleptic Sales by Type 2.3.1 Global Neuroleptic Sales Market Share by Type (2017-2022) 2.3.2 Global Neuroleptic Revenue and Market Share by Type (2017-2022) 2.3.3 Global Neuroleptic Sale Price by Type (2017-2022) 2.4 Neuroleptic Segment by Application 2.4.1 Medical Care 2.4.2 Scientific Research 2.4.3 Others 2.5 Neuroleptic Sales by Application 2.5.1 Global Neuroleptic Sale Market Share by Application (2017-2022) 2.5.2 Global Neuroleptic Revenue and Market Share by Application (2017-2022) 2.5.3 Global Neuroleptic Sale Price by Application (2017-2022) 3 Global Neuroleptic by Company 3.1 Global Neuroleptic Breakdown Data by Company 3.1.1 Global Neuroleptic Annual Sales by Company (2020-2022) 3.1.2 Global Neuroleptic Sales Market Share by Company (2020-2022) 3.2 Global Neuroleptic Annual Revenue by Company (2020-2022) 3.2.1 Global Neuroleptic Revenue by Company (2020-2022) 3.2.2 Global Neuroleptic Revenue Market Share by Company (2020-2022) 3.3 Global Neuroleptic Sale Price by Company 3.4 Key Manufacturers Neuroleptic Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Neuroleptic Product Location Distribution 3.4.2 Players Neuroleptic Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Neuroleptic by Geographic Region 4.1 World Historic Neuroleptic Market Size by Geographic Region (2017-2022) 4.1.1 Global Neuroleptic Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Neuroleptic Annual Revenue by Geographic Region 4.2 World Historic Neuroleptic Market Size by Country/Region (2017-2022) 4.2.1 Global Neuroleptic Annual Sales by Country/Region (2017-2022) 4.2.2 Global Neuroleptic Annual Revenue by Country/Region 4.3 Americas Neuroleptic Sales Growth 4.4 APAC Neuroleptic Sales Growth 4.5 Europe Neuroleptic Sales Growth 4.6 Middle East & Africa Neuroleptic Sales Growth 5 Americas 5.1 Americas Neuroleptic Sales by Country 5.1.1 Americas Neuroleptic Sales by Country (2017-2022) 5.1.2 Americas Neuroleptic Revenue by Country (2017-2022) 5.2 Americas Neuroleptic Sales by Type 5.3 Americas Neuroleptic Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Neuroleptic Sales by Region 6.1.1 APAC Neuroleptic Sales by Region (2017-2022) 6.1.2 APAC Neuroleptic Revenue by Region (2017-2022) 6.2 APAC Neuroleptic Sales by Type 6.3 APAC Neuroleptic Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Neuroleptic by Country 7.1.1 Europe Neuroleptic Sales by Country (2017-2022) 7.1.2 Europe Neuroleptic Revenue by Country (2017-2022) 7.2 Europe Neuroleptic Sales by Type 7.3 Europe Neuroleptic Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Neuroleptic by Country 8.1.1 Middle East & Africa Neuroleptic Sales by Country (2017-2022) 8.1.2 Middle East & Africa Neuroleptic Revenue by Country (2017-2022) 8.2 Middle East & Africa Neuroleptic Sales by Type 8.3 Middle East & Africa Neuroleptic Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Neuroleptic 10.3 Manufacturing Process Analysis of Neuroleptic 10.4 Industry Chain Structure of Neuroleptic 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Neuroleptic Distributors 11.3 Neuroleptic Customer 12 World Forecast Review for Neuroleptic by Geographic Region 12.1 Global Neuroleptic Market Size Forecast by Region 12.1.1 Global Neuroleptic Forecast by Region (2023-2028) 12.1.2 Global Neuroleptic Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Neuroleptic Forecast by Type 12.7 Global Neuroleptic Forecast by Application 13 Key Players Analysis 13.1 Johnson & Johnso 13.1.1 Johnson & Johnso Company Information 13.1.2 Johnson & Johnso Neuroleptic Product Offered 13.1.3 Johnson & Johnso Neuroleptic Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Johnson & Johnso Main Business Overview 13.1.5 Johnson & Johnso Latest Developments 13.2 Pfizer 13.2.1 Pfizer Company Information 13.2.2 Pfizer Neuroleptic Product Offered 13.2.3 Pfizer Neuroleptic Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Pfizer Main Business Overview 13.2.5 Pfizer Latest Developments 13.3 Eli Lilly 13.3.1 Eli Lilly Company Information 13.3.2 Eli Lilly Neuroleptic Product Offered 13.3.3 Eli Lilly Neuroleptic Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Eli Lilly Main Business Overview 13.3.5 Eli Lilly Latest Developments 13.4 Bristol-Myers Squibb 13.4.1 Bristol-Myers Squibb Company Information 13.4.2 Bristol-Myers Squibb Neuroleptic Product Offered 13.4.3 Bristol-Myers Squibb Neuroleptic Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Bristol-Myers Squibb Main Business Overview 13.4.5 Bristol-Myers Squibb Latest Developments 13.5 GlaxoSmithKline 13.5.1 GlaxoSmithKline Company Information 13.5.2 GlaxoSmithKline Neuroleptic Product Offered 13.5.3 GlaxoSmithKline Neuroleptic Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 GlaxoSmithKline Main Business Overview 13.5.5 GlaxoSmithKline Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Neuroleptic Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Neuroleptic Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Droperidol Table 4. Major Players of Midazolam Table 5. Global Neuroleptic Sales by Type (2017-2022) & (K Pcs) Table 6. Global Neuroleptic Sales Market Share by Type (2017-2022) Table 7. Global Neuroleptic Revenue by Type (2017-2022) & ($ million) Table 8. Global Neuroleptic Revenue Market Share by Type (2017-2022) Table 9. Global Neuroleptic Sale Price by Type (2017-2022) & (USD/Pcs) Table 10. Global Neuroleptic Sales by Application (2017-2022) & (K Pcs) Table 11. Global Neuroleptic Sales Market Share by Application (2017-2022) Table 12. Global Neuroleptic Revenue by Application (2017-2022) Table 13. Global Neuroleptic Revenue Market Share by Application (2017-2022) Table 14. Global Neuroleptic Sale Price by Application (2017-2022) & (USD/Pcs) Table 15. Global Neuroleptic Sales by Company (2020-2022) & (K Pcs) Table 16. Global Neuroleptic Sales Market Share by Company (2020-2022) Table 17. Global Neuroleptic Revenue by Company (2020-2022) ($ Millions) Table 18. Global Neuroleptic Revenue Market Share by Company (2020-2022) Table 19. Global Neuroleptic Sale Price by Company (2020-2022) & (USD/Pcs) Table 20. Key Manufacturers Neuroleptic Producing Area Distribution and Sales Area Table 21. Players Neuroleptic Products Offered Table 22. Neuroleptic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Neuroleptic Sales by Geographic Region (2017-2022) & (K Pcs) Table 26. Global Neuroleptic Sales Market Share Geographic Region (2017-2022) Table 27. Global Neuroleptic Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Neuroleptic Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Neuroleptic Sales by Country/Region (2017-2022) & (K Pcs) Table 30. Global Neuroleptic Sales Market Share by Country/Region (2017-2022) Table 31. Global Neuroleptic Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Neuroleptic Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Neuroleptic Sales by Country (2017-2022) & (K Pcs) Table 34. Americas Neuroleptic Sales Market Share by Country (2017-2022) Table 35. Americas Neuroleptic Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Neuroleptic Revenue Market Share by Country (2017-2022) Table 37. Americas Neuroleptic Sales by Type (2017-2022) & (K Pcs) Table 38. Americas Neuroleptic Sales Market Share by Type (2017-2022) Table 39. Americas Neuroleptic Sales by Application (2017-2022) & (K Pcs) Table 40. Americas Neuroleptic Sales Market Share by Application (2017-2022) Table 41. APAC Neuroleptic Sales by Region (2017-2022) & (K Pcs) Table 42. APAC Neuroleptic Sales Market Share by Region (2017-2022) Table 43. APAC Neuroleptic Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Neuroleptic Revenue Market Share by Region (2017-2022) Table 45. APAC Neuroleptic Sales by Type (2017-2022) & (K Pcs) Table 46. APAC Neuroleptic Sales Market Share by Type (2017-2022) Table 47. APAC Neuroleptic Sales by Application (2017-2022) & (K Pcs) Table 48. APAC Neuroleptic Sales Market Share by Application (2017-2022) Table 49. Europe Neuroleptic Sales by Country (2017-2022) & (K Pcs) Table 50. Europe Neuroleptic Sales Market Share by Country (2017-2022) Table 51. Europe Neuroleptic Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Neuroleptic Revenue Market Share by Country (2017-2022) Table 53. Europe Neuroleptic Sales by Type (2017-2022) & (K Pcs) Table 54. Europe Neuroleptic Sales Market Share by Type (2017-2022) Table 55. Europe Neuroleptic Sales by Application (2017-2022) & (K Pcs) Table 56. Europe Neuroleptic Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Neuroleptic Sales by Country (2017-2022) & (K Pcs) Table 58. Middle East & Africa Neuroleptic Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Neuroleptic Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Neuroleptic Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Neuroleptic Sales by Type (2017-2022) & (K Pcs) Table 62. Middle East & Africa Neuroleptic Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Neuroleptic Sales by Application (2017-2022) & (K Pcs) Table 64. Middle East & Africa Neuroleptic Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Neuroleptic Table 66. Key Market Challenges & Risks of Neuroleptic Table 67. Key Industry Trends of Neuroleptic Table 68. Neuroleptic Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Neuroleptic Distributors List Table 71. Neuroleptic Customer List Table 72. Global Neuroleptic Sales Forecast by Region (2023-2028) & (K Pcs) Table 73. Global Neuroleptic Sales Market Forecast by Region Table 74. Global Neuroleptic Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Neuroleptic Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Neuroleptic Sales Forecast by Country (2023-2028) & (K Pcs) Table 77. Americas Neuroleptic Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Neuroleptic Sales Forecast by Region (2023-2028) & (K Pcs) Table 79. APAC Neuroleptic Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Neuroleptic Sales Forecast by Country (2023-2028) & (K Pcs) Table 81. Europe Neuroleptic Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Neuroleptic Sales Forecast by Country (2023-2028) & (K Pcs) Table 83. Middle East & Africa Neuroleptic Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Neuroleptic Sales Forecast by Type (2023-2028) & (K Pcs) Table 85. Global Neuroleptic Sales Market Share Forecast by Type (2023-2028) Table 86. Global Neuroleptic Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Neuroleptic Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Neuroleptic Sales Forecast by Application (2023-2028) & (K Pcs) Table 89. Global Neuroleptic Sales Market Share Forecast by Application (2023-2028) Table 90. Global Neuroleptic Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Neuroleptic Revenue Market Share Forecast by Application (2023-2028) Table 92. Johnson & Johnso Basic Information, Neuroleptic Manufacturing Base, Sales Area and Its Competitors Table 93. Johnson & Johnso Neuroleptic Product Offered Table 94. Johnson & Johnso Neuroleptic Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 95. Johnson & Johnso Main Business Table 96. Johnson & Johnso Latest Developments Table 97. Pfizer Basic Information, Neuroleptic Manufacturing Base, Sales Area and Its Competitors Table 98. Pfizer Neuroleptic Product Offered Table 99. Pfizer Neuroleptic Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 100. Pfizer Main Business Table 101. Pfizer Latest Developments Table 102. Eli Lilly Basic Information, Neuroleptic Manufacturing Base, Sales Area and Its Competitors Table 103. Eli Lilly Neuroleptic Product Offered Table 104. Eli Lilly Neuroleptic Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 105. Eli Lilly Main Business Table 106. Eli Lilly Latest Developments Table 107. Bristol-Myers Squibb Basic Information, Neuroleptic Manufacturing Base, Sales Area and Its Competitors Table 108. Bristol-Myers Squibb Neuroleptic Product Offered Table 109. Bristol-Myers Squibb Neuroleptic Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 110. Bristol-Myers Squibb Main Business Table 111. Bristol-Myers Squibb Latest Developments Table 112. GlaxoSmithKline Basic Information, Neuroleptic Manufacturing Base, Sales Area and Its Competitors Table 113. GlaxoSmithKline Neuroleptic Product Offered Table 114. GlaxoSmithKline Neuroleptic Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 115. GlaxoSmithKline Main Business Table 116. GlaxoSmithKline Latest Developments List of Figures Figure 1. Picture of Neuroleptic Figure 2. Neuroleptic Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Neuroleptic Sales Growth Rate 2017-2028 (K Pcs) Figure 7. Global Neuroleptic Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Neuroleptic Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Droperidol Figure 10. Product Picture of Midazolam Figure 11. Global Neuroleptic Sales Market Share by Type in 2021 Figure 12. Global Neuroleptic Revenue Market Share by Type (2017-2022) Figure 13. Neuroleptic Consumed in Medical Care Figure 14. Global Neuroleptic Market: Medical Care (2017-2022) & (K Pcs) Figure 15. Neuroleptic Consumed in Scientific Research Figure 16. Global Neuroleptic Market: Scientific Research (2017-2022) & (K Pcs) Figure 17. Neuroleptic Consumed in Others Figure 18. Global Neuroleptic Market: Others (2017-2022) & (K Pcs) Figure 19. Global Neuroleptic Sales Market Share by Application (2017-2022) Figure 20. Global Neuroleptic Revenue Market Share by Application in 2021 Figure 21. Neuroleptic Revenue Market by Company in 2021 ($ Million) Figure 22. Global Neuroleptic Revenue Market Share by Company in 2021 Figure 23. Global Neuroleptic Sales Market Share by Geographic Region (2017-2022) Figure 24. Global Neuroleptic Revenue Market Share by Geographic Region in 2021 Figure 25. Global Neuroleptic Sales Market Share by Region (2017-2022) Figure 26. Global Neuroleptic Revenue Market Share by Country/Region in 2021 Figure 27. Americas Neuroleptic Sales 2017-2022 (K Pcs) Figure 28. Americas Neuroleptic Revenue 2017-2022 ($ Millions) Figure 29. APAC Neuroleptic Sales 2017-2022 (K Pcs) Figure 30. APAC Neuroleptic Revenue 2017-2022 ($ Millions) Figure 31. Europe Neuroleptic Sales 2017-2022 (K Pcs) Figure 32. Europe Neuroleptic Revenue 2017-2022 ($ Millions) Figure 33. Middle East & Africa Neuroleptic Sales 2017-2022 (K Pcs) Figure 34. Middle East & Africa Neuroleptic Revenue 2017-2022 ($ Millions) Figure 35. Americas Neuroleptic Sales Market Share by Country in 2021 Figure 36. Americas Neuroleptic Revenue Market Share by Country in 2021 Figure 37. United States Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 38. Canada Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 39. Mexico Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 40. Brazil Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 41. APAC Neuroleptic Sales Market Share by Region in 2021 Figure 42. APAC Neuroleptic Revenue Market Share by Regions in 2021 Figure 43. China Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 44. Japan Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 45. South Korea Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 46. Southeast Asia Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 47. India Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 48. Australia Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 49. Europe Neuroleptic Sales Market Share by Country in 2021 Figure 50. Europe Neuroleptic Revenue Market Share by Country in 2021 Figure 51. Germany Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 52. France Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 53. UK Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 54. Italy Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 55. Russia Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 56. Middle East & Africa Neuroleptic Sales Market Share by Country in 2021 Figure 57. Middle East & Africa Neuroleptic Revenue Market Share by Country in 2021 Figure 58. Egypt Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 59. South Africa Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 60. Israel Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 61. Turkey Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 62. GCC Country Neuroleptic Revenue Growth 2017-2022 ($ Millions) Figure 63. Manufacturing Cost Structure Analysis of Neuroleptic in 2021 Figure 64. Manufacturing Process Analysis of Neuroleptic Figure 65. Industry Chain Structure of Neuroleptic Figure 66. Channels of Distribution Figure 67. Distributors Profiles